BIOMEDITECH ApS: Financial statements 2017
CVR: 34707847
Source: annual report 2017, Danish Business Authority
01/01/2017 – 31/12/2017
BIOMEDITECH ApS (CVR 34707847) has filed annual accounts for 2017. In 2017, the company reported a net result of DKK -28,108 compared with DKK -31,246 the year before. Equity in the 2017 report amounted to DKK 64,928. The solvency ratio was 92.3%.
- Profit/Loss
- DKK -28,108
- Equity
- DKK 64,928
- Total Assets
- DKK 70,316
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2017 | - | - | -28 t. | 65 t. | - |
| 2016 | - | - | -31 t. | 93 t. | - |
| 2015 | 0 | 0 | 0 | 124 t. | - |
| 2014 | 0 | 0 | 35 | 124 t. | - |
Official annual report
Keep an eye on BIOMEDITECH ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2017
BIOMEDITECH ApS has published its annual report for 2016. The net result was DKK -31,246.
About BIOMEDITECH ApS
BIOMEDITECH ApS is a Danish company of the type Anpartsselskab based in Herlev, founded in 2012. The company is registered under the industry Engroshandel med andre maskiner og andet udstyr. The company was previously named DRUG TESTING EUROPE ApS. The management consists of Tobias Chalmer Stahl Rasmussen. The company is owned by Chalmer Holding ApS. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK 106,895 and a net result of DKK -6,298 compared with DKK 290,046 the year before. Equity in the 2025 report amounted to DKK 877,884.